Elevated concentrations of circulating intercellular adhesion molecule 1 (Icam-1) in HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 6, Issue 3, 1993, Pages 221-226

  Möst, Johannes ^a   Zangerle, Robert ^a   Herold, Manfred ^a   Fuchs, Dietmar ^b,c   Wachter, Helmut ^b,c   Fritsch, Peter ^a   Dierich, Manfred P ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

HIV 1; ICAM 1; IL 6; Neopterin

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MEMBRANE PROTEIN; NEOPTERIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; T LYMPHOCYTE;

ADULT; BIOPTERIN; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; FEMALE; HIV INFECTIONS; HIV-1; HUMAN; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; NEOPTERIN; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0027415001     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Fauci AS. lmmunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114:678-93.
2. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985; 313:79-84.
3. Lahdevirta J. Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:289-91.
4. Fuchs D, Hausen A, Reibnegger G, et al. Interferon-γconcentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 1989; 2:158-62.
5. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144:480-4.
6. Birx DL, Redfield RR, Tenter K, Fowler A, Burke DS, Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76:2303-10.
7. Honda M, Kitamura K, Mizutani Y, et al. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J Immunol 1990; 145: 4059-64.
8. Poli G, Kinter A, Justement JS, et al. Tumor necrosis factor αfunctions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 1990; 87:782-5.
9. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. J Exp Med 1990; 172:151-8.
10. Krämer A, Wiktor SZ, Fuchs D, et al. Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1989; 2:291-6.
11. Fuchs D, Spira TJ, Hausen A, et al. Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Clin Chem 1989; 35:1746-9.
12. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1, N Engl J Med 1990; 322:166-72.
13. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-l demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52:925-33.
14. Rothlein R, Dustin ML, Marlin SD, Springer TA, A human intercellular adhesion molecule (ICAM-l) distinct from LFA-1. J Immunol 1986; 137:1270-4.
15. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-l) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987; 51:813-9.
16. Diamond MS, Staunton DE, de Fougerolles AR, et al. ICAM-l (CD54): a counter-receptor for Mac-1 (CDIlb/CDI8). J Cell Biol 1990; 111:3129-39.
17. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-I) interaction with intercellular adhesion molecule-l (ICAM-l) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988; 107:321-31.
18. Altmann DM, Hogg N, Trowsdale J, Wilkinson D, Cotransfection of ICAM-l and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature (Lond) 1989; 338:512-4.
19. Makgoba MW, Sanders ME, Ginther Luce GE, et al. Functional evidence that intercellular adhesion molecule-l (ICAM-l) is a ligand for LFA-I-dependent adhesion in T cell mediated cytotoxicity. Eur J Immunol 1988; 18:637-40.
20. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-l. Cell 1989; 56:839-47.
21. Staunton DK, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. A cell adhesion molecule, ICAM-l, is the major surface receptor for rhinoviruses. Cell 1989; 56:849-53.
22. Berendt AR, Simmons DL, Tansey J, Newbold CI. Marsh K. Intercellular adhesion molecule-l is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature (Land) 1989; 341:57-9.
23. van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-l provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990; 144:4579-86.
24. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-l). J Immunol 1986; 137:245-54.
25. Dustin ML, Staunton DE, Springer TA. Supergene families meet in the immune system. Immunol Today 1988; 9:213-5.
26. Schulz TF, Mitterer M, Vogetseder W, Böck G, Myones BL, Dierich MP. Identification and characterization of a novel membrane activation antigen with wide cellular distribution. Eur J Immunol 1988; 18:7-11.
27. Most J, Schwaeble W, Drach J, Sommerauer A, Dierich MP. Regulation of the expression of ICAM-l on human monocytes and monocytic tumor cell lines. J Immunol 1992; 148: 1635-42.
28. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-l (ICAM-l) in the pathogenesis of asthma. Science 1990; 247:456-9.
29. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989; 2:1122-5.
30. Johnson JP, Stade BG, Holzmann B, Schwaeble W, Riethmüller G. De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989; 86:641-4.
31. Vogetseder W, Feichtinger H, Schulz TF, et al. Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-l (ICAM-l) in human carcinomas and their stromal fibroblasts. Int J Cancer 1989; 43:768-73.
32. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-l isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338:83-4.
33. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-l in human serum. J Immunal 1991; 147: 3788-93.
34. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating intercellular molecule-l antigen in malignant diseases. Clin Exp Immunol 1991; 85:3-8.
35. Harning R, Mainolfi E, Bystryn J-C, Henn M, Merluzzi VJ, Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1992; 51:5003-5.
36. Hofbauer JM, Schulz TF, Hengster P, et al. Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections. J Clin Microbiol 1988; 26: 116-20.
37. Schulz TF, Oberhuber W, Hofbauer JM, et al. Recombinant peptides derived from the env-gene of HIV-2 in the serodiagnosis of HIV-2 infections. AIDS 1989; 3:165-72.
38. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27:81-141.
39. Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135:3172-7.
40. Fujimoto J, Levy S, Levy R. Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med 1983; 159:752-66.
41. Kloster BE, John PA. Miller LE, et al. Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS. Clin Immunol Immunopalhol 1987; 45: 440-6.
42. Prince HE, Kleinman S, Williams AE. Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. J Immunol 1988; 140:1139-41.
43. Agostini C, Semenzato G, Vinante F, et al. Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders. Clin Immunol Immunopalhol 1989; 50: 146-53.
44. Reddy MM, Lange M, Grieco MH. Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations. J Clin Microbiol 1989; 27:257-60.
45. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today 1988; 9:150-5.
46. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. Shedding of ICAM-l from human melanoma cell lines induced by IFN-γand tumor necrosis factor-α. Functional consequences on cell-mediated cytotoxicity. J Immunol 1991; 147:4398-401.
47. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160:310-6.
48. Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Merluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature (Land) 1990; 344:70-2.
49. Pantaleo G, Butini L, Graziosi C, et al. Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-I: LFA-I is required for HIV-1 mediated cell fusion but not for viral transmission. J Exp Med 1991; 173:511-4.
50. Vermot-Desroches C, Rigal D, Escaich S, et al. Functional epitope analysis of the human CD 11a/CD 18 molecule (LFA-I, lymphocyte function-associated antigen 1) involved in HIV-l-induced syncytium formation. Scand J Immunol 1991; 34:461-70.